This page has beta status

BMBS COST Action B29
Chronic Obstructive Pulmonary Disease

The main objective of the COST Action B29 is to identify the best definition and

characterisation of COPD-Exac and their role in the natural history of COPD with the key

purpose to better understand COPD-related morbidity and mortality.

Secondary objectives are: a) the definition of clinical, functional and biological outcomes to

assess therapeutic strategies in management programmes; b) a more detailed understanding of

underlying pathogenic mechanisms and aetiological factors; c) the optimisation and

integration of treatment and preventive strategies in order to reduce the social and personal

burden of the abrupt events, with integration of these preventive determinants in

comprehensive management programmes for COPD; and, d) new models of patient centred

health care by implementation of optimal self-management and substitution of care.

The major benefit of this concerted effort is the improvement of patient care, management and

treatment of COPD-Exac. Such an ambitious goal can have a major beneficial impact on

mortality and morbidity.

(Descriptions are provided by the Actions directly via e-COST.)

General Information*

Chair of the Action:

Prof Jadwiga WEDZICHA (UK)

Vice Chair of the Action:

Prof Emiel WOUTERS (NL)

Science officer of the Action:


Administrative officer of the Action:

Ms Gabriela CRISTEA


Action Fact Sheet

Download AFS as .RTF

Memorandum of Understanding

Download MoU as PDF

Progress Report

Download Progress Report as PDF


Last updated: 02 May 2011 top of page